Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14329 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Jennifer E Marvin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus, Cytomegalovirus Infections, Drug Therapy, Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut, USA.
- Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Jennifer E Marvin, Marwan M Azar
Zitieren
APA
Marvin, J. E., Trubin, P. A., & Azar, M. M. (2024). Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transplant Infectious Disease. https://doi.org/10.1111/tid.14329
Vancouver
Marvin JE, Trubin PA, Azar MM. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transplant Infectious Disease. 2024. doi:10.1111/tid.14329
BibTeX
@article{Marvin2024,
author = {Marvin, Jennifer E and Trubin, Paul Albert and Azar, Marwan M},
title = {Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14329}
}
EUVIMED